Clinical trial
Pilot Single-center Open Study of the Effect of Ingaron on the Efficacy and Resistance to Antibiotics in Antibacterial Therapy in Patients With Community-acquired Pneumonia
NCT05395702 is registered in ClinicalTrials.gov with SPP Pharmaclon Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Single-center Open Study of the Effect of Ingaron on the Efficacy and Resistance to Antibiotics in Antibacterial Therapy in Patients With Community-acquired Pneumonia
- Lead sponsor
- SPP Pharmaclon Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 12, 2017
- Completion date
- May 30, 2019
- Enrollment
- 114 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.